Package 62541-202-30

{"route": ["ORAL"], "spl_id": "3e4dec6d-5fe5-ec19-e063-6394a90a35d6", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "upc": ["0362541202306", "0362541203303", "0362541204300", "0362541201309"], "unii": ["0K2I505OTV", "0H73WJJ391"], "rxcui": ["1302827", "1302833", "1302839", "1302845", "1302850", "1302856", "1313059", "1313061"], "spl_set_id": ["40dd5602-53da-45ac-bb4b-15789aba40f9"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Vivus LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, UNIT-DOSE (62541-202-30)", "package_ndc": "62541-202-30", "marketing_start_date": "20120917"}], "brand_name": "Qsymia", "product_id": "62541-202_3e4dec6d-5fe5-ec19-e063-6394a90a35d6", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Appetite Suppression [PE]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Increased Sympathetic Activity [PE]", "Sympathomimetic Amine Anorectic [EPC]"], "product_ndc": "62541-202", "dea_schedule": "CIV", "generic_name": "phentermine and topiramate", "labeler_name": "Vivus LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Qsymia", "active_ingredients": [{"name": "PHENTERMINE HYDROCHLORIDE", "strength": "7.5 mg/1"}, {"name": "TOPIRAMATE", "strength": "46 mg/1"}], "application_number": "NDA022580", "marketing_category": "NDA", "marketing_start_date": "20120917", "listing_expiration_date": "20261231"}